Clinical Trial Update: A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002012) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating autologous dermal and epidermal cell injections for hair loss in androgenetic alopecia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia
• Female Pattern Hair Loss
• Male Pattern Baldness

Drugs mentioned

• Autologous dermal and epidermal cell injections

Snippet

Sponsor: Aderans Research Institute | Conditions: Androgenetic Alopecia, Male Pattern Baldness | Phase 2 | Status: COMPLETED